SavedAdd your journal

Journals / Southern Clinics of Istanbul Eurasia / 2021 / Cilt: 32 - Sayı: 2

The Relationship Between SII, PLR, LCR, MPV/PLT Values and COVID-19 Prognosis

Mustafa ÇÖRTÜK
Binnaz Zeynep YILDIRIM
Erdoğan ÇETİNKAYA
Efsun Gonca UĞUR CHOUSEIN
Demet TURAN
Elif TANRIVERDİ
Halit ÇINARKA
Celal Buğra SEZEN
Melih Akay ARSLAN
Pages
109–115
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patients were divided into a non-severe group and a severe disease group, which was defined by a respiratory rate of >30/minute or an oxygen saturation

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The magnitude of the coronavirus 2019 (COVID-19) pandemic has produced a great need to determine laboratory parameters of prognostic significance.
📊
Key Findings & Data:The aim of this study was to determine the usefulness of systemic-immune- inflammation index (SII), lymphocyte-to-CRP ratio (LCR), platelet-to-lymphocyte ratio (PLR) and mean thrombocyte volume-to-platelet count ratio (MPV/PLT) values compared with the commonly used laboratory parameters of absolute lymphocyte count, neutrophil-to-lymphocyte ratio (NLR), and C-reactive protein (CRP), as prognostic biomarkers of COVID-19.
💡
Conclusion & Impact:The patients were divided into a non-severe group and a severe disease group, which was defined by a respiratory rate of >30/minute or an oxygen saturation
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The magnitude of the coronavirus 2019 (COVID-19) pandemic has produced a great need to determine laboratory parameters of prognostic significance. This information will help identify patients at risk of severe disease and assist in the optimal allocation of limited medical resources. The aim of this study was to determine the usefulness of systemic-immune- inflammation index (SII), lymphocyte-to-CRP ratio (LCR), platelet-to-lymphocyte ratio (PLR) and mean thrombocyte volume-to-platelet count ratio (MPV/PLT) values compared with the commonly used laboratory parameters of absolute lymphocyte count, neutrophil-to-lymphocyte ratio (NLR), and C-reactive protein (CRP), as prognostic biomarkers of COVID-19. Methods: The medical records of patients hospitalized with COVID-19 pneumonia between March 2020 and May 2020 were retrospectively evaluated. The NLR, PLR, LCR, SII, and MPV/PLT values were calculated based on laboratory parameters. The need for oxygen support, non-invasive mechanical ventilation (NIMV), and intensive care treatment were documented, as well as mortal outcomes. The patients were divided into a non-severe group and a severe disease group, which was defined by a respiratory rate of >30/minute or an oxygen saturation

🔖

Cite This Article

ÇÖRTÜK, M., YILDIRIM, B. Z., ÇETİNKAYA, E., CHOUSEIN, E. G. U., TURAN, D., TANRIVERDİ, E., ÇINARKA, H., SEZEN, C. B., ARSLAN, M. A. (2022). The Relationship Between SII, PLR, LCR, MPV/PLT Values and COVID-19 Prognosis. Southern Clinics of Istanbul Eurasia, Cilt: 32 - Sayı: 2, 109–115. https://ajindex.com/articles/592748

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019- nCoV) infection in China — Wuhan, Hubei Province, 2019–2020. China CDC Weekly 2020;2:79-80
  2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al; China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-33
  3. Sattar N, McInnes IB, McMurray JJV. Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation 2020;142:4-6
  4. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 2020;71:762-8
  5. Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995;107:1062- 73
  6. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 2020;58:1021– 8
  7. Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte- to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. J Med Virol 2020;92:1733–4
  8. Zheng F, Tang W, Li H, Huang YX, Xie YL, Zhou ZG. Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha. Eur Rev Med Pharmacol Sci 2020;24:3404–10
  9. Li L, Zhang B, He B, Gong Z, Chen X. Critical patients with coronavirus disease 2019: Risk factors and outcome nomogram. J Infect 2020;80:37–8
  10. Qu R, Ling Y, Zhang YH, Wei LY, Chen X, Li XM, et al. Platelet- to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol 2020;92:1533−41
  11. Zuo H, Xie X, Peng J, Wang L, Zhu R. Predictive value of novel inflammation-based biomarkers for pulmonary hypertension in the acute exacerbation of chronic obstructive pulmonary disease. Anal Cell Pathol (Amst) 2019;2019:5189165
  12. Liu J, Li S, Zhang S, Liu Y, Ma L, Zhu J, et al. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with niv